Editorial writers tackle these public health issues.

Nearly 1 in 3 Americans — in the only wealthy country in the world to not have a developed universal health care system — lack reliable primary care access. Meanwhile, unlike JD Vance, Americans are ...

Health insurance companies are expected to pull back slightly from Medicare Advantage investing in 2025. Instead, Modern Healthcare reports, they will focus on Dual-Eligible Special Needs Plans, or ...

A new study discovered that live virus replication was detectable in semen in a patient infected with Oropouche virus some 16 days after symptom onset, suggesting a risk of sexual transmission.

New Drug Pricing Policy Could Raise Costs For Millions It's troubling that among Americans over 64, a full 25% struggle to afford their medicines, according to a poll by the Kaiser Family Foundation.

The Wall Street Journal reports that Danco, the pharmaceutical company that makes mifepristone under the label Mifeprex, plans to apply for FDA approval for use of the drug in managing miscarriages.

Meanwhile, demand for vaccines targeting respiratory syncytial virus are down in the U.S. Also, if you are uncertain about whether you might have covid or the flu, the newly approved at-home Healgen ...

Axios reports the Biden administration today will release a preliminary list of generic drugs for Medicare recipients that would cost no more than $2 out of pocket. The pilot program aims to test drug ...

The company is leaning on its global plants to help meet production demands after its Helene-damaged facility in North Carolina temporarily shut down. Meanwhile, hospitals, health care facilities, and ...

Compounding pharmacies sued the FDA after its declaration, bringing an end to the sale of the "copycat" drugs they provide. Meanwhile, as demand soars for weight loss drugs, WeightWatchers eyes ...

Vice President Kamala Harris says if elected president she will push for increased Medicare coverage of long-term care services in the home for aging patients. Her campaign also talked about drug ...

The Big Three pharmacy benefit managers say they return nearly all the rebates they get from drugmakers to the employers and ...